Unresectable Or Metastatic Conventional Chondrosarcoma clinical trials

Explore recruiting unresectable or metastatic conventional chondrosarcoma clinical trials.

Also recruiting in Europe

Unresectable Or Metastatic Conventional Chondrosarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Blinded, Placebo-Controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma

France, Italy, Germany, Ireland, Netherlands, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Unresectable Or Metastatic Conventional Chondrosarcoma trials by city

Unresectable Or Metastatic Conventional Chondrosarcoma in Toronto Unresectable Or Metastatic Conventional Chondrosarcoma in Vancouver Unresectable Or Metastatic Conventional Chondrosarcoma in Montreal Unresectable Or Metastatic Conventional Chondrosarcoma in Calgary Unresectable Or Metastatic Conventional Chondrosarcoma in Edmonton Unresectable Or Metastatic Conventional Chondrosarcoma in Ottawa Unresectable Or Metastatic Conventional Chondrosarcoma in Winnipeg Unresectable Or Metastatic Conventional Chondrosarcoma in Quebec City Unresectable Or Metastatic Conventional Chondrosarcoma in Hamilton Unresectable Or Metastatic Conventional Chondrosarcoma in Kitchener Unresectable Or Metastatic Conventional Chondrosarcoma in London Unresectable Or Metastatic Conventional Chondrosarcoma in Halifax Unresectable Or Metastatic Conventional Chondrosarcoma in New York Unresectable Or Metastatic Conventional Chondrosarcoma in Los Angeles Unresectable Or Metastatic Conventional Chondrosarcoma in Chicago Unresectable Or Metastatic Conventional Chondrosarcoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease